604 related articles for article (PubMed ID: 35309213)
1. Emergence of Hypervirulent ST11-K64
Wei T; Zou C; Qin J; Tao J; Yan L; Wang J; Du H; Shen F; Zhao Y; Wang H
Front Public Health; 2022; 10():765624. PubMed ID: 35309213
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of molecular and clinical characteristics of carbapenem-resistant hypervirulent
Lei J; Zhou WX; Lei K; Chen D; Zhang PQ; Xue L; Geng Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jan; 56(1):63-68. PubMed ID: 35092993
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Tigecycline Nonsusceptible and IMP-4 Carbapenemase-Producing K2-ST65 Hypervirulent Klebsiella pneumoniae in China.
Zhang Y; Wang X; Wang Q; Chen H; Li H; Wang S; Wang R; Wang H
Microbiol Spectr; 2021 Oct; 9(2):e0130521. PubMed ID: 34704778
[TBL] [Abstract][Full Text] [Related]
4. Infection with Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae: clinical, virulence and molecular epidemiological characteristics.
Li L; Li S; Wei X; Lu Z; Qin X; Li M
Antimicrob Resist Infect Control; 2023 Nov; 12(1):124. PubMed ID: 37953357
[TBL] [Abstract][Full Text] [Related]
5. Detection of carbapenem-resistant hypervirulent Klebsiella pneumoniae ST11-K64 co-producing NDM-1 and KPC-2 in a tertiary hospital in Wuhan.
Huang Y; Li J; Wang Q; Tang K; Cai X; Li C
J Hosp Infect; 2023 Jan; 131():70-80. PubMed ID: 36183928
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital.
Ouyang P; Jiang B; Peng N; Wang J; Cai L; Wu Y; Ye J; Chen Y; Yuan H; Tan C; Tan L; Xie L
J Clin Lab Anal; 2022 Jun; 36(6):e24476. PubMed ID: 35522153
[TBL] [Abstract][Full Text] [Related]
7. An Outbreak of ST859-K19 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Teaching Hospital.
Zhu J; Jiang X; Zhao L; Li M
mSystems; 2022 Jun; 7(3):e0129721. PubMed ID: 35574716
[TBL] [Abstract][Full Text] [Related]
8.
Yu F; Lv J; Niu S; Du H; Tang YW; Bonomo RA; Kreiswirth BN; Chen L
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891605
[TBL] [Abstract][Full Text] [Related]
9. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
Zhang Y; Jin L; Ouyang P; Wang Q; Wang R; Wang J; Gao H; Wang X; Wang H;
J Antimicrob Chemother; 2020 Feb; 75(2):327-336. PubMed ID: 31713615
[TBL] [Abstract][Full Text] [Related]
10. Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
Ahmed MAEE; Yang Y; Yang Y; Yan B; Chen G; Hassan RM; Zhong LL; Chen Y; Roberts AP; Wu Y; He R; Liang X; Qin M; Dai M; Zhang L; Li H; Yang F; Xu L; Tian GB
mSphere; 2021 May; 6(3):. PubMed ID: 34011682
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Carbapenem-Resistant Hypervirulent
Hu D; Chen W; Zhang Q; Li M; Yang Z; Wang Y; Huang Y; Li G; Tian D; Fu P; Wang W; Ren P; Mu Q; Yu L; Jiang X
Front Cell Infect Microbiol; 2022; 12():882210. PubMed ID: 35719357
[TBL] [Abstract][Full Text] [Related]
13. Emergence of NDM-5-Producing Carbapenem-Resistant
Li Q; Zhu J; Kang J; Song Y; Yin D; Guo Q; Song J; Zhang Y; Wang S; Duan J
Infect Drug Resist; 2020; 13():3075-3089. PubMed ID: 32943891
[TBL] [Abstract][Full Text] [Related]
14. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant
Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F
mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656
[TBL] [Abstract][Full Text] [Related]
15. An Outbreak of Carbapenem-Resistant
Zeng L; Yang C; Zhang J; Hu K; Zou J; Li J; Wang J; Huang W; Yin L; Zhang X
Front Cell Infect Microbiol; 2021; 11():656070. PubMed ID: 34150672
[TBL] [Abstract][Full Text] [Related]
16. [Molecular epidemiological characterization of hypervirulent carbapenem-resistant
Liu XW; Li DZ; Hu Y; Zhu R; Liu DM; Guo MY; Ren YY; Li YF; Li YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Aug; 57(8):1222-1230. PubMed ID: 37574316
[No Abstract] [Full Text] [Related]
17. Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae.
Zhou Y; Wu C; Wang B; Xu Y; Zhao H; Guo Y; Wu X; Yu J; Rao L; Wang X; Yu F
Drug Resist Updat; 2023 Mar; 67():100918. PubMed ID: 36610180
[TBL] [Abstract][Full Text] [Related]
18.
Hao M; Shi X; Lv J; Niu S; Cheng S; Du H; Yu F; Tang YW; Kreiswirth BN; Zhang H; Chen L
Front Microbiol; 2020; 11():425. PubMed ID: 32231657
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent
Xie M; Ye L; Chen K; Xu Q; Yang C; Chen X; Chan EW; Li F; Chen S
Emerg Microbes Infect; 2024 Dec; 13(1):2306957. PubMed ID: 38240375
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant hypermucoviscous
Wang Q; Chen M; Ou Q; Zheng L; Chen X; Mao G; Fang J; Jin D; Tang X
Front Cell Infect Microbiol; 2022; 12():1083009. PubMed ID: 36619764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
